MYDA Advisors’s Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 FPAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23,625
Closed -$7K 235
2022
Q2
$7K Buy
+23,625
New +$18.2K ﹤0.01% 196
2021
Q3
Sell
-24,000
Closed -$34K 329
2021
Q2
$34K Buy
+24,000
New +$24.3K 0.01% 274

Other funds holding FPAC.WS

MYDA Advisors's FPAC.WS Position: Q3 2022 in Review

MYDA Advisors sold out of Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (FPAC.WS) in Q3 2022, closing a stake of 23,625 shares — an estimated $7K sold.

MYDA Advisors first reported a position in FPAC.WS in Q2 2021 and held it in 2 quarters. The position peaked at $34K in Q2 2021. 30 funds tracked by Wall St. Rank hold FPAC.WS as of Q3 2022.

  • MYDA Advisors reported no remaining Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • MYDA Advisors sold 23,625 Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $7K.
  • MYDA Advisors first reported a position in Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 2 quarters.
  • MYDA Advisors's Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $34K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on MYDA Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.